LG CNS Showcases Pharma Manufacturing Automation at CPHI Milan

LG CNS is participating in CPHI Milan 2026 to showcase its manufacturing automation solutions tailored for the pharmaceutical industry. At the event, the company is highlighting technologies under the theme "Autonomous Factory in Pharma," covering factory design, production operations, and quality management.

The participation in the world's largest pharmaceutical and biotechnology trade show in Milan is part of LG CNS's strategy to broaden the application of its autonomous factory solutions within the pharmaceutical sector. The company seeks to address the industry's growing demand for automation, focusing on improving production efficiency and meeting stringent quality standards.

The solutions presented by LG CNS are designed to enhance the overall automation of factory functions. This includes leveraging data in factory design, real-time production monitoring and optimization, and automated quality control systems. The objective is to create smarter and more flexible manufacturing environments.

According to the company, the adoption of its technology enables greater predictability in manufacturing processes and reduces errors, which is critical in a regulated field like the pharmaceutical industry. LG CNS aims to assist pharmaceutical companies in boosting their productivity while ensuring product safety and quality.